New Delhi, Aug. 12 -- The Molbio Diagnostics IPO has entered its final day of subscription, giving investors one last opportunity to place their bids today, August 12.

Molbio Diagnostics IPO has received stellar response from investors across all categories. The mainboard IPO had opened for bidding on 10 August.

Established in October 2000, Molbio Diagnostics Ltd. is a global molecular diagnostics firm involved in developing, manufacturing and commercialising rapid diagnostic solutions for infectious as well as non-communicable diseases.

The company's key offering is its proprietary Truenat platform, a portable, battery-operated, PCR-based molecular diagnostic system capable of delivering accurate test results within an hour. The platf...